HK1200117A1 - 包含含有噻托銨的組合物的吸入器 - Google Patents

包含含有噻托銨的組合物的吸入器

Info

Publication number
HK1200117A1
HK1200117A1 HK15100682.6A HK15100682A HK1200117A1 HK 1200117 A1 HK1200117 A1 HK 1200117A1 HK 15100682 A HK15100682 A HK 15100682A HK 1200117 A1 HK1200117 A1 HK 1200117A1
Authority
HK
Hong Kong
Prior art keywords
tiotropium
inhaler
composition
Prior art date
Application number
HK15100682.6A
Other languages
English (en)
Inventor
Xian-Ming Zeng
Derek Fenlon
Original Assignee
Teva Branded Pharmaceutical Prod R & D Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45788842&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1200117(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Branded Pharmaceutical Prod R & D Inc filed Critical Teva Branded Pharmaceutical Prod R & D Inc
Publication of HK1200117A1 publication Critical patent/HK1200117A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/04—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0091—Inhalators mechanically breath-triggered
    • A61M15/0095—Preventing manual activation in absence of inhalation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK15100682.6A 2011-12-19 2015-01-21 包含含有噻托銨的組合物的吸入器 HK1200117A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161577314P 2011-12-19 2011-12-19
GB201200504A GB201200504D0 (en) 2011-12-19 2012-01-13 An inhaler
PCT/EP2012/075230 WO2013092345A1 (en) 2011-12-19 2012-12-12 An inhaler comprising a tiotropium-containing-composition

Publications (1)

Publication Number Publication Date
HK1200117A1 true HK1200117A1 (zh) 2015-07-31

Family

ID=45788842

Family Applications (2)

Application Number Title Priority Date Filing Date
HK15100682.6A HK1200117A1 (zh) 2011-12-19 2015-01-21 包含含有噻托銨的組合物的吸入器
HK15100891.3A HK1200341A1 (zh) 2011-12-19 2015-01-27 包含含有噻托銨的組合物的吸入器

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK15100891.3A HK1200341A1 (zh) 2011-12-19 2015-01-27 包含含有噻托銨的組合物的吸入器

Country Status (22)

Country Link
US (1) US20140373832A1 (zh)
EP (2) EP2800567B1 (zh)
JP (1) JP2015502220A (zh)
KR (2) KR20150118195A (zh)
CN (1) CN104010640A (zh)
AR (1) AR089597A1 (zh)
AU (1) AU2012358128B2 (zh)
BR (1) BR112014014536A2 (zh)
CA (1) CA2856054C (zh)
DK (2) DK2606892T3 (zh)
EA (1) EA029047B1 (zh)
ES (2) ES2593281T3 (zh)
GB (1) GB201200504D0 (zh)
HK (2) HK1200117A1 (zh)
HU (2) HUE034667T2 (zh)
IL (1) IL232945B (zh)
MX (1) MX357619B (zh)
PL (2) PL2606892T3 (zh)
TW (1) TWI524905B (zh)
UY (1) UY34526A (zh)
WO (1) WO2013092345A1 (zh)
ZA (1) ZA201403042B (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
WO2013127738A1 (de) * 2012-02-28 2013-09-06 Boehringer Ingelheim International Gmbh Neue treibgashaltige tiotropium-formulierung
US9636425B2 (en) * 2012-09-18 2017-05-02 Focal Point Technologies, Llc Method of dry dye delivery for staining the eye
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
US20190054010A1 (en) * 2015-10-29 2019-02-21 3M Innovative Properties Company Formulation and aerosol canisters, inhalers, and the like containing the formulation
US11071837B2 (en) 2015-12-21 2021-07-27 Kindeva Drug Delivery L.P. Dose release firing systems and medicinal inhalers comprising same
WO2017112451A1 (en) * 2015-12-21 2017-06-29 3M Innovative Properties Company Auto-reset dose release firing systems, medicinal inhalers comprising same, and methods of using same
GB2553535A (en) * 2016-09-07 2018-03-14 3M Innovative Properties Co Trigger mechansim for an inhaler
GB2553534A (en) * 2016-09-07 2018-03-14 3M Innovative Properties Co Trigger mechanism for an inhaler
GB201702407D0 (en) 2017-02-14 2017-03-29 Norton (Waterford) Ltd Inhalers and related methods
GB201702408D0 (en) * 2017-02-14 2017-03-29 Norton (Waterford) Ltd Inhalers and related methods
WO2020006017A1 (en) * 2018-06-27 2020-01-02 3M Innovative Properties Company Tiotropium formulation and inhaler
FR3089127B1 (fr) * 2018-11-30 2020-11-20 Aptar France Sas Dispositif de distribution de produit fluide synchronisé avec l'inhalation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9026191D0 (en) * 1990-12-01 1991-01-16 Harris Pharma Ltd Breath actuated dispensing device
GB2264238A (en) 1992-05-29 1993-08-25 Norton Healthcare Ltd Medicament inhalor device
WO1994013262A1 (en) 1992-12-09 1994-06-23 Boehringer Ingelheim Pharmaceuticals, Inc. Stabilized medicinal aerosol solution formulations
SK286694B6 (sk) * 2000-05-22 2009-03-05 Chiesi Farmaceutici S.P.A. Aerosólový farmaceutický prostriedok
US6553988B1 (en) 2000-06-09 2003-04-29 Norton Healthcare, Inc. Medicament dispensing device with a multimaterial diaphragm bounding a pneumatic force chamber
DE10214263A1 (de) 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
US7311894B2 (en) 2002-03-28 2007-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations containing an anticholinergic
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
KR20050085650A (ko) * 2002-12-16 2005-08-29 베링거 잉겔하임 파르마 게엠베하 운트 코 카게 타이오트로피움 함유 ｈｆｃ 용액 제형
US20060079544A1 (en) * 2004-08-13 2006-04-13 Boehringer Ingelheim International Gmbh Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic
EP2201934A1 (en) * 2008-12-23 2010-06-30 CHIESI FARMACEUTICI S.p.A. Tiotropium aerosol formulation products with improved chemical stability
KR20120109504A (ko) 2009-11-17 2012-10-08 시플라 리미티드 흡입 용액

Also Published As

Publication number Publication date
PL2800567T3 (pl) 2018-04-30
DK2800567T3 (da) 2017-11-06
CA2856054C (en) 2016-11-22
EP2606892B1 (en) 2016-08-24
EP2606892A1 (en) 2013-06-26
TW201341000A (zh) 2013-10-16
NZ711668A (en) 2017-01-27
KR20140096159A (ko) 2014-08-04
EA029047B1 (ru) 2018-02-28
MX357619B (es) 2018-07-17
JP2015502220A (ja) 2015-01-22
IL232945A0 (en) 2014-07-31
MX2014007358A (es) 2014-11-21
TWI524905B (zh) 2016-03-11
DK2606892T3 (en) 2016-09-26
EP2800567B1 (en) 2017-09-27
ZA201403042B (en) 2016-08-31
PL2606892T3 (pl) 2017-02-28
KR20150118195A (ko) 2015-10-21
EA201491205A1 (ru) 2014-10-30
HUE030015T2 (en) 2017-04-28
NZ624160A (en) 2016-05-27
US20140373832A1 (en) 2014-12-25
IL232945B (en) 2018-05-31
ES2593281T3 (es) 2016-12-07
AU2012358128A1 (en) 2014-05-22
ES2644572T3 (es) 2017-11-29
EP2800567A1 (en) 2014-11-12
GB201200504D0 (en) 2012-02-22
HUE034667T2 (en) 2018-02-28
BR112014014536A2 (pt) 2017-06-13
UY34526A (es) 2014-07-31
WO2013092345A1 (en) 2013-06-27
CN104010640A (zh) 2014-08-27
CA2856054A1 (en) 2013-06-27
AR089597A1 (es) 2014-09-03
KR101629119B1 (ko) 2016-06-09
AU2012358128B2 (en) 2015-09-17
HK1200341A1 (zh) 2015-08-07

Similar Documents

Publication Publication Date Title
HK1250206A1 (zh) 吸入器組件
HK1219031A1 (zh) 吸入器組件
HK1196511A1 (zh) 吸入器組件
HK1198435A1 (zh) 吸入器
AU342595S (en) Inhaler device
PL2865403T3 (pl) Inhalator
PL2719416T3 (pl) Inhalator aerozolowy
HK1200341A1 (zh) 包含含有噻托銨的組合物的吸入器
HK1198734A1 (zh) 足部測量器
HK1198692A1 (zh) 吸入器
LT2672846T (lt) Inhaliavimo įrenginys
EP2731657A4 (en) HUMIDIFIERS
AU343374S (en) Inhaler
ZA201507856B (en) An inhaler comprising a tiotropium-containing-composition
AU342092S (en) Inhaler
AU342046S (en) Inhaler
AU342045S (en) Inhaler
AU342091S (en) Inhaler
AU344099S (en) Inhaler
AU344100S (en) Inhaler
AU344082S (en) Inhaler
NZ607285A (en) Inhaler
AU337359S (en) Inhaler
GB201122489D0 (en) A hand-glove
GB201122100D0 (en) A footgauge